An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real-world practice setting: A report from the Fenfluramine European Early Access Program.
Renzo GuerriniNicola SpecchioAngel Aledo-SerranoMilka PringsheimFrancesca DarraThomas MayerAntonio Gil-NagelTilman PolsterSameer M ZuberiAmélie LotheArnold R GammaitoniAdam StrzelczykPublished in: Epilepsia open (2022)
The magnitude, consistency, and durability of the response to add-on fenfluramine is consistent across age groups in patients with Dravet syndrome.